Megan Washington
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Megan Washington has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Austin Christofferson
Translational Genomics Research Institute, Phoenix, AZ, United States of America
1 shared publication- Daniel Auclair
Multiple Myeloma Research Foundation, Norwalk, USA
1 shared publication - Daniel C. Rohrer
Van Andel Institute, Grand Rapids, USA
1 shared publication David Wesley Craig
Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America
1 shared publicationJessica Aldrich
Translational Genomics Research Institute, Phoenix, AZ, United States of America
1 shared publicationJohn D. Carpten
Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America
1 shared publication
Latest Publications
- Open Access
- 22 November 2017
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 13 (11) , e1007087
Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases
Multiple Myeloma (MM) is a plasma cell malignancy with significantly greater incidence and mortality rates among African Americans (AA) compared to Caucasians (CA). The overall goal of this study is to elucidate differences in molecular alterations in MM as a function of self-reported race and genetic ancestry. Our study utilized somatic whole exome, RNA-sequencing, and correlated clinical data from 718 MM patients from the Multiple Myeloma Research Foundation CoMMpass study Interim Analysis 9. Somatic mutational analyses based upon self-reported race corrected for ancestry revealed significant differences in mutation frequency between groups. Of interest, BCL7A, BRWD3, and AUTS2 demonstrate significantly higher mutation frequencies among AA cases. These genes are all involved in translocations in B-cell malignancies. Moreover, we detected a significant difference in mutation frequency of TP53 and IRF4 with frequencies higher among CA cases. Our study provides rationale for interrogating diverse tumor cohorts to best understand tumor genomics across populations. This study represents the largest comprehensive molecular analysis of ethnically defined newly diagnosed treatment naïve Multiple Myeloma (MM). We revealed significant differences in mutation frequencies for important cancer genes between AA and CA MM. This study provides support for interrogating diverse tumor cohorts to best understand tumor genomics across populations.
- 22 November 2017
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 13 (11) , e1007087
Open AccessComprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases
Multiple Myeloma (MM) is a plasma cell malignancy with significantly greater incidence and mortality rates among African Americans (AA) compared to Caucasians (CA). The overall goal of this study is to elucidate differences in molecular alterations in MM as a function of self-reported race and genetic ancestry. Our study utilized somatic whole exome, RNA-sequencing, and correlated clinical data from 718 MM patients from the Multiple Myeloma Research Foundation CoMMpass study Interim Analysis 9. Somatic mutational analyses based upon self-reported race corrected for ancestry revealed significant differences in mutation frequency between groups. Of interest, BCL7A, BRWD3, and AUTS2 demonstrate significantly higher mutation frequencies among AA cases. These genes are all involved in translocations in B-cell malignancies. Moreover, we detected a significant difference in mutation frequency of TP53 and IRF4 with frequencies higher among CA cases. Our study provides rationale for interrogating diverse tumor cohorts to best understand tumor genomics across populations. This study represents the largest comprehensive molecular analysis of ethnically defined newly diagnosed treatment naïve Multiple Myeloma (MM). We revealed significant differences in mutation frequencies for important cancer genes between AA and CA MM. This study provides support for interrogating diverse tumor cohorts to best understand tumor genomics across populations.